| Factor Information | |
|---|---|
| Data ID | 684 |
| Factor | Volume of RBCs transfusions |
| Description | N/A |
| Biomarker | NA |
| Classification | A12 (clinical factor - treatment) |
| Association | |
|---|---|
| Application | treatment |
| Objective | neonate and infant with CHD |
| p Value | 0.005 |
| Conclusion | The thrombosis group had significantly more RBC transfusions compared to the non-thrombosis group. |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 138 |
| CHD Type | isolated CHD/non-isolated CHD |
| CHD Subtype | NA |
| Reference | |
|---|---|
| PMID | 29044074 |
| Year | 2018 |
| Title | Haem is associated with thrombosis in neonates and infants undergoing cardiac surgery for congenital heart disease. |
| Sample | ||
|---|---|---|
| Population | neonate and infant | |
| Source | blood | |
| Region | USA, NY | |
| Method | T-test | |
| Race | American | |
| Disease History | N/A | |
| Treatment History | cardiac operation | |
| Group | thrombosis(Treatment) | no thrombosis(Control) |
| Number | 15 | 24 |
| Age | 3±6.2 months | 12.6±14.7 months |
| Gender (Male: Female) | 5:10 | 11:13 |
| Marker Level | 868±1215 mL | 348±127 ml |
